NM_000535.7(PMS2):c.245G>T (p.Gly82Val) AND Hereditary cancer-predisposing syndrome

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: May 11, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002455475.2

Allele description [Variation Report for NM_000535.7(PMS2):c.245G>T (p.Gly82Val)]

NM_000535.7(PMS2):c.245G>T (p.Gly82Val)

Gene:

PMS2:PMS1 homolog 2, mismatch repair system component [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

7p22.1

Genomic location:

Preferred name:

NM_000535.7(PMS2):c.245G>T (p.Gly82Val)

HGVS:

NC_000007.14:g.6003977C>A
NG_008466.1:g.10130G>T
NM_000535.7:c.245G>TMANE SELECT
NM_001018040.1:c.-161G>T
NM_001322003.2:c.-161G>T
NM_001322004.2:c.-161G>T
NM_001322005.2:c.-161G>T
NM_001322006.2:c.245G>T
NM_001322007.2:c.30G>T
NM_001322008.2:c.30G>T
NM_001322009.2:c.-161G>T
NM_001322010.2:c.-161G>T
NM_001322011.2:c.-640G>T
NM_001322012.2:c.-640G>T
NM_001322013.2:c.-161G>T
NM_001322014.2:c.245G>T
NM_001322015.2:c.-240G>T
NM_001406866.1:c.431G>T
NM_001406868.1:c.245G>T
NM_001406869.1:c.245G>T
NM_001406870.1:c.245G>T
NM_001406871.1:c.245G>T
NM_001406872.1:c.245G>T
NM_001406873.1:c.245G>T
NM_001406874.1:c.245G>T
NM_001406875.1:c.-240G>T
NM_001406876.1:c.30G>T
NM_001406877.1:c.-240G>T
NM_001406878.1:c.-240G>T
NM_001406879.1:c.-240G>T
NM_001406880.1:c.-187G>T
NM_001406881.1:c.-137G>T
NM_001406882.1:c.-240G>T
NM_001406883.1:c.30G>T
NM_001406884.1:c.245G>T
NM_001406885.1:c.245G>T
NM_001406886.1:c.245G>T
NM_001406887.1:c.-161G>T
NM_001406888.1:c.-108G>T
NM_001406889.1:c.-108G>T
NM_001406890.1:c.-151G>T
NM_001406891.1:c.-161G>T
NM_001406892.1:c.-108G>T
NM_001406893.1:c.-161G>T
NM_001406894.1:c.-108G>T
NM_001406895.1:c.-108G>T
NM_001406897.1:c.-161G>T
NM_001406898.1:c.-161G>T
NM_001406899.1:c.-108G>T
NM_001406900.1:c.-137G>T
NM_001406901.1:c.30G>T
NM_001406902.1:c.30G>T
NM_001406903.1:c.30G>T
NM_001406904.1:c.-108G>T
NM_001406905.1:c.-161G>T
NM_001406906.1:c.-161G>T
NM_001406907.1:c.-108G>T
NM_001406908.1:c.-161G>T
NM_001406909.1:c.-108G>T
NM_001406910.1:c.-161G>T
NM_001406911.1:c.-161G>T
NM_001406912.1:c.245G>T
NP_000526.1:p.Gly82Val
NP_000526.2:p.Gly82Val
NP_001308935.1:p.Gly82Val
NP_001308936.1:p.Arg10Ser
NP_001308937.1:p.Arg10Ser
NP_001308943.1:p.Gly82Val
NP_001393795.1:p.Gly144Val
NP_001393797.1:p.Gly82Val
NP_001393798.1:p.Gly82Val
NP_001393799.1:p.Gly82Val
NP_001393800.1:p.Gly82Val
NP_001393801.1:p.Gly82Val
NP_001393802.1:p.Gly82Val
NP_001393803.1:p.Gly82Val
NP_001393805.1:p.Arg10Ser
NP_001393812.1:p.Arg10Ser
NP_001393813.1:p.Gly82Val
NP_001393814.1:p.Gly82Val
NP_001393815.1:p.Gly82Val
NP_001393830.1:p.Arg10Ser
NP_001393831.1:p.Arg10Ser
NP_001393832.1:p.Arg10Ser
NP_001393841.1:p.Gly82Val
LRG_161t1:c.245G>T
LRG_161:g.10130G>T
LRG_161p1:p.Gly82Val
NC_000007.13:g.6043608C>A
NM_000535.5:c.245G>T
NR_003085.2:n.327G>T
NR_136154.1:n.332G>T

Protein change:

G144V

Molecular consequence:

NM_001322003.2:c.-161G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322004.2:c.-161G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322005.2:c.-161G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322009.2:c.-161G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322010.2:c.-161G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322011.2:c.-640G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322012.2:c.-640G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322013.2:c.-161G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322015.2:c.-240G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_000535.7:c.245G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001322006.2:c.245G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001322007.2:c.30G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001322008.2:c.30G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001322014.2:c.245G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001406866.1:c.431G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001406868.1:c.245G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001406869.1:c.245G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001406870.1:c.245G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001406871.1:c.245G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001406872.1:c.245G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001406873.1:c.245G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001406874.1:c.245G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001406876.1:c.30G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001406883.1:c.30G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001406884.1:c.245G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001406885.1:c.245G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001406886.1:c.245G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001406901.1:c.30G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001406902.1:c.30G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001406903.1:c.30G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001406912.1:c.245G>T - missense variant - [Sequence Ontology: SO:0001583]
NR_136154.1:n.332G>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:: Hereditary cancer-predisposing syndrome
Synonyms:: Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Clear Turn Off Turn On

Pohlia cruda voucher HBNU:He Qiang 698 AtpB (atpB) gene, partial cds; atpB-rbcL ...
Pohlia cruda voucher HBNU:He Qiang 698 AtpB (atpB) gene, partial cds; atpB-rbcL intergenic spacer, complete sequence; and ribulose-1,5-bisphosphate carboxylase/oxygenase large subunit (rbcL) gene, partial cds; chloroplast
gi|1226142150|gb|KX355906.1|

Nucleotide
Pohlia cruda isolate OK1808 internal transcribed spacer 1, partial sequence
Pohlia cruda isolate OK1808 internal transcribed spacer 1, partial sequence
gi|1418017752|gb|MG733064.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002736049	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (May 11, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002736049

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(May 11, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV002736049.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The p.G82V variant (also known as c.245G>T), located in coding exon 3 of the PMS2 gene, results from a G to T substitution at nucleotide position 245. The glycine at codon 82 is replaced by valine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: May 1, 2024

ClinVar

Relating variation to medicine